Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
This clinical trial update discusses the implications of BCL6 rearrangements across non-Hodgkin lymphomas, including follicular lymphoma, ma…
-
CLINICAL_TRIALS research · 2017-10-24Clinical Trial Update: Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluates the combination of Rituximab with autologous effector lymphocytes in follicular lymphoma patients respond…
-
CLINICAL_TRIALS research · 2017-08-29Clinical Trial Update: Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
This clinical trial update reports on blood immunophenotyping techniques to aid staging of indolent B-cell lymphomas, including Follicular L…
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of CT-1530 in relapsed or refractory B-cell non-Hodgkin lymphoma, chronic lymphocyt…
-
CLINICAL_TRIALS research · 2017-06-27Clinical Trial Update: DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701
This clinical trial update reports findings from DNA analysis aimed at predicting which follicular lymphoma patients respond to antibody the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
This completed clinical trial update discusses biomarker analyses in samples from patients with Follicular lymphoma treated with Rituximab.
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma
This clinical trial update describes an observational study assessing treatments, outcomes, and prognosis for patients with follicular lymph…
-
CLINICAL_TRIALS research · 2017-03-16Clinical Trial Update: Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma [Phase 1, Phase 2]
This document describes a Phase 1/2 clinical trial evaluating competitive transfer of two αCD19-TCRz-CAR-T cell constructs (one with CD28 an…
-
CLINICAL_TRIALS research · 2017-03-09Clinical Trial Update: Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
Administrative update reporting procurement of follicular B cell lymphoma cells for potential use in future clinical trials.
-
CLINICAL_TRIALS research · 2016-11-09Clinical Trial Update: Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis
A single-center retrospective analysis of 237 patients with follicular lymphoma describing the various causes of death observed in this coho…
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: An Italian Experience on Grade 3b Follicular Lymphoma
The document reports an Italian clinical trial experience related to Grade 3b Follicular Lymphoma, outlining observational findings and insi…
-
CLINICAL_TRIALS research · 2016-10-05Clinical Trial Update: Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma [NA]
The update investigates the clinical and prognostic relevance of sarcopenia in patients over 70 with diffuse large B-cell lymphoma, highligh…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]
Clinical trial update describing CART19 therapy for relapsed and/or chemotherapy-refractory B-cell malignancies with an unknown status of th…
-
CLINICAL_TRIALS research · 2015-09-29Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of a genetically engineered lymphocyte therapy for chemotherapy-resistant or refrac…
-
CLINICAL_TRIALS research · 2015-04-22Clinical Trial Update: Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma [Phase 3]
Phase 3 clinical trial assessing first-line bendamustine plus rituximab, followed by maintenance rituximab, in patients with follicular lymp…
-
CLINICAL_TRIALS research · 2014-07-24Clinical Trial Update: S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone
A completed clinical trial update focusing on blood and tissue samples from patients with follicular lymphoma treated with Rituximab, Cyclop…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma [Phase 3]
Phase 3 clinical trial comparing chlorambucil with radiation therapy in previously untreated stage III or stage IV follicular lymphoma.
-
CLINICAL_TRIALS research · 2013-08-23Clinical Trial Update: Trial of Rituximab, Bendamustine (RB) for Patients With Follicular Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line [Phase 2]
This is a Phase 2 clinical trial update for Rituximab plus Bendamustine in follicular lymphoma patients who are refractory or relapsed after…
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma [Phase 2]
Clinical trial update of a Phase 2 study evaluating GM-CSF, Rituximab, and combination chemotherapy in patients with previously untreated ad…
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma [Phase 2]
This clinical trial update describes a Phase 2 study of GM-CSF with Rituximab in previously untreated follicular lymphoma.
-
CLINICAL_TRIALS research · 2012-08-02Clinical Trial Update: Zevalin® First Line in Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating Zevalin (ibritumomab tiuxetan) as first-line therapy for Follicular Lymphoma; no results or current status are prov…
-
CLINICAL_TRIALS research · 2011-10-13Clinical Trial Update: Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma [Phase 2]
A multicenter Phase II pilot trial assessing the efficacy and safety of LR-CHOP21 in elderly patients with untreated diffuse large B-cell ly…
-
CLINICAL_TRIALS research · 2011-02-15Clinical Trial Update: Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma [Phase 3]
A Phase 3 multicenter randomized trial comparing three rituximab-containing regimens (R-CVP, R-CHOP, and R-FM) in patients with stage II-IV …
-
CLINICAL_TRIALS research · 2010-06-28Clinical Trial Update: Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy
A clinical trial update evaluating patient- and lesion-specific prognostic factors for standard radioimmunotherapy in follicular lymphoma; s…